143 related articles for article (PubMed ID: 37490266)
1. Is unicentric familial papillary thyroid microcarcinoma different from multicentric?
Ríos A; Ruiz-Pardo J; Balaguer-Román A; Puñal JA; Moreno P; Mercader E; Ferrero E; Morlán MA; Martín J; Durán M; Bravo JM; Casanova D; Salvador-Egea MP; Torregrosa NM; Exposito-Rodríguez A; Martínez-Fernández G; Carrión AM; Vidal O; Herrera F; Ruiz-Merino G; Rodríguez JM
Endocrine; 2023 Dec; 82(3):613-621. PubMed ID: 37490266
[TBL] [Abstract][Full Text] [Related]
2. Is familial papillary thyroid microcarcinoma more aggressive than sporadic form?
Lee CR; Park S; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY; Park CS
Ann Surg Treat Res; 2017 Mar; 92(3):129-135. PubMed ID: 28289666
[TBL] [Abstract][Full Text] [Related]
3. Biological behavior of familial papillary thyroid microcarcinoma: Spanish multicenter study.
Ríos A; Rodríguez MA; Puñal JA; Moreno P; Mercader E; Ferrero E; Ruiz-Pardo J; Morlán MA; Martín J; Durán-Poveda M; Bravo JM; Casanova D; Egea MPS; Torregrosa NM; Exposito-Rodríguez A; Martínez-Fernández G; Carrión AM; Vidal O; Herrera F; Ruiz-Merino G; Rodríguez JM
Langenbecks Arch Surg; 2022 Dec; 407(8):3631-3642. PubMed ID: 36251077
[TBL] [Abstract][Full Text] [Related]
4. High recurrent rate of multicentric papillary thyroid carcinoma.
Lin JD; Chao TC; Hsueh C; Kuo SF
Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance and outcome of familial papillary thyroid cancer: a single institution study of 626 familial cases.
Li Z; Zhang H; Yan Y; Li X; Jia M; Zhou H; Lu X
Front Endocrinol (Lausanne); 2023; 14():1200855. PubMed ID: 37780622
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of Papillary Thyroid Microcarcinoma Presenting with Palpable Lateral Lymphadenopathy.
Papachristos A; Do K; Tsang VH; Sywak M; Gill AJ; Sidhu S; Clifton-Bligh RJ; Glover A; Gild ML
Thyroid; 2022 Sep; 32(9):1086-1093. PubMed ID: 35703333
[No Abstract] [Full Text] [Related]
7. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
8. Familial papillary thyroid microcarcinoma: a new clinical entity.
Lupoli G; Vitale G; Caraglia M; Fittipaldi MR; Abbruzzese A; Tagliaferri P; Bianco AR
Lancet; 1999 Feb; 353(9153):637-9. PubMed ID: 10030330
[TBL] [Abstract][Full Text] [Related]
9. Impact of major different variants of papillary thyroid microcarcinoma on the clinicopathological characteristics: the study of 1041 cases.
Zhi J; Zhao J; Gao M; Pan Y; Wu J; Li Y; Li D; Yu Y; Zheng X
Int J Clin Oncol; 2018 Feb; 23(1):59-65. PubMed ID: 28744725
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic central neck dissection and local recurrence in papillary thyroid microcarcinoma: a meta-analysis.
Su H; Li Y
Braz J Otorhinolaryngol; 2019; 85(2):237-243. PubMed ID: 30017872
[TBL] [Abstract][Full Text] [Related]
11. Treatment for microcarcinoma of the thyroid--clinical experience.
Küçük NO; Tari P; Tokmak E; Aras G
Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
[TBL] [Abstract][Full Text] [Related]
12. Aggressive variants of papillary thyroid microcarcinoma are associated with extrathyroidal spread and lymph-node metastases: a population-level analysis.
Kuo EJ; Goffredo P; Sosa JA; Roman SA
Thyroid; 2013 Oct; 23(10):1305-11. PubMed ID: 23600998
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors of Metastatic Lymph Nodes in Papillary Thyroid Microcarcinoma.
Ruiz Pardo J; Ríos A; Rodríguez JM; Paredes M; Soriano V; Oviedo MI; Hernández AM; Parrilla P
Cir Esp (Engl Ed); 2020 Apr; 98(4):219-225. PubMed ID: 31980154
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors affecting neck lymph node recurrence and distant metastasis in papillary microcarcinoma of the thyroid: results of a study in 445 patients.
Mercante G; Frasoldati A; Pedroni C; Formisano D; Renna L; Piana S; Gardini G; Valcavi R; Barbieri V
Thyroid; 2009 Jul; 19(7):707-16. PubMed ID: 19348581
[TBL] [Abstract][Full Text] [Related]
15. Radioactive iodine ablation does not prevent recurrences in patients with papillary thyroid microcarcinoma.
Kim HJ; Kim NK; Choi JH; Kim SW; Jin SM; Suh S; Bae JC; Min YK; Chung JH; Kim SW
Clin Endocrinol (Oxf); 2013 Apr; 78(4):614-20. PubMed ID: 22957654
[TBL] [Abstract][Full Text] [Related]
16. Does extracapsular extension impact the prognosis of papillary thyroid microcarcinoma?
Chéreau N; Buffet C; Trésallet C; Tissier F; Golmard JL; Leenhardt L; Menegaux F
Ann Surg Oncol; 2014 May; 21(5):1659-64. PubMed ID: 24394985
[TBL] [Abstract][Full Text] [Related]
17. Total thyroidectomy versus lobectomy in conventional papillary thyroid microcarcinoma: Analysis of 8,676 patients at a single institution.
Kim SK; Park I; Woo JW; Lee JH; Choe JH; Kim JH; Kim JS
Surgery; 2017 Feb; 161(2):485-492. PubMed ID: 27593085
[TBL] [Abstract][Full Text] [Related]
18. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.
Mazzaferri EL; Jhiang SM
Am J Med; 1994 Nov; 97(5):418-28. PubMed ID: 7977430
[TBL] [Abstract][Full Text] [Related]
19. The effects of surgery, radioiodine, and external radiation therapy on the clinical outcome of patients with differentiated thyroid carcinoma.
Tsang RW; Brierley JD; Simpson WJ; Panzarella T; Gospodarowicz MK; Sutcliffe SB
Cancer; 1998 Jan; 82(2):375-88. PubMed ID: 9445196
[TBL] [Abstract][Full Text] [Related]
20. Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up.
Pedrazzini L; Baroli A; Marzoli L; Guglielmi R; Papini E
Minerva Endocrinol; 2013 Sep; 38(3):269-79. PubMed ID: 24126547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]